Menu

• Ask a Health Expert about CARBOHYDRATE ANTIGEN 19-9 INCREASED
• Post Your Side Effect related to CARBOHYDRATE ANTIGEN 19-9 INCREASED
• CARBOHYDRATE ANTIGEN 19-9 INCREASED and FDA Warnings
• CARBOHYDRATE ANTIGEN 19-9 INCREASED in Patients Wiki
• Report CARBOHYDRATE ANTIGEN 19-9 INCREASED in Drug Side Effect Survey

CARBOHYDRATE ANTIGEN 19-9 INCREASED side effect

What is CARBOHYDRATE ANTIGEN 19-9 INCREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Protonix Side Effects Report #5649329-X
Physician from UNITED STATES reported PROTONIX problem on Feb 21, 2008. Female patient, weighting 130.1 lb, was diagnosed with hiatus hernia and was treated with PROTONIX. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, decreased appetite, weight decreased, . PROTONIX dosage: unknown. Patient recovered.

Pegasys Side Effects Report #5638907-X
PEGASYS problem was reported by a Physician from BULGARIA on Feb 14, 2008. Male patient, 47 years of age, weighting 165.3 lb, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, . PEGASYS dosage: unknown. During the same period patient was treated with COPEGUS. Patient recovered.

Protonix Side Effects Report #5565064-0
Health Professional from UNITED STATES reported PROTONIX problem on Dec 06, 2007. Female patient, weighting 130.1 lb, was diagnosed with hiatus hernia and was treated with PROTONIX. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, . PROTONIX dosage: unknown. Patient recovered.

Gemzar Side Effects Report #5569362-6
GEMZAR problem was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 77 years of age, was diagnosed with bile duct cancer recurrent and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, gastroduodenal haemorrhage, neutropenia, shock haemorrhagic, . GEMZAR dosage: 800 MG, OTHER. During the same period patient was treated with FLUOROURACIL, THERAPEUTIC RADIOPHARMACEUTICALS. Patient died.


Propecia Side Effects Report #5574783-1
Physician from JAPAN reported PROPECIA problem on Dec 20, 2007. Male patient, 56 years of age, weighting 167.6 lb, was diagnosed with male pattern baldness and was treated with PROPECIA. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, libido decreased, malaise, organic erectile dysfunction, penile size reduced, testicular pain, . PROPECIA dosage: unknown. Patient recovered.

Propecia Side Effects Report #5530787-6
PROPECIA problem was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, 56 years of age, weighting 167.6 lb, was diagnosed with male pattern baldness and was treated with PROPECIA. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, malaise, testicular pain, . PROPECIA dosage: unknown. Patient recovered.

Xeloda Side Effects Report #5696153-8
Consumer or non-health professional from CHINA reported XELODA problem on Mar 25, 2008. Female patient, 44 years of age, weighting 110.2 lb, was diagnosed with gastric cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, carcinoembryonic antigen increased, . XELODA dosage: unknown. Patient recovered.

Gemzar Side Effects Report #5697132-7
GEMZAR problem was reported by a Physician from JAPAN on Mar 28, 2008. Female patient, 70 years of age, weighting 103.6 lb, was diagnosed with gastric cancer recurrent and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, disseminated intravascular coagulation, nausea, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN. Patient died on 04/01/2005.

Gemzar Side Effects Report #5352624-5
Physician from JAPAN reported GEMZAR problem on May 30, 2007. Male patient, 74 years of age, was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, neoplasm recurrence, neutrophil count decreased, . GEMZAR dosage: 1000 MG/M2, OTHER. Patient recovered.


Bevacizumab Side Effects Report #5268674-3
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Female patient, weighting 94.00 lb, was diagnosed with colon cancer, metastases to liver and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, dehydration, diarrhoea, hyponatraemia, nausea, pancreatitis, . BEVACIZUMAB dosage: 5MG/KG Q 2 WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5648860-0
Physician from SPAIN reported FORTEO problem on Feb 27, 2008. Female patient, 60 years of age, was diagnosed with osteoporotic fracture and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, carbohydrate antigen 19-9 increased, echinococciasis, weight decreased, . FORTEO dosage: unknown. Patient recovered.

Lapatinib Side Effects Report #5563225-8
LAPATINIB problem was reported by a Health Professional from UNITED STATES on Dec 13, 2007. Male patient, weighting 187.4 lb, was diagnosed with pancreatic carcinoma and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: anorexia, carbohydrate antigen 19-9 increased, cerebral artery embolism, cerebrovascular accident, fatigue, nausea, . LAPATINIB dosage: 1500 MG DAILY PO. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5450540-1
Consumer or non-health professional from UNITED STATES reported REBIF problem on Aug 29, 2007. Female patient, 44 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: appendix disorder, carbohydrate antigen 19-9 increased, endometriosis, hepatic cyst, neuralgia, pollakiuria, rectocele repair, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5443526-4
REBIF problem was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Female patient, 44 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: appendix disorder, carbohydrate antigen 19-9 increased, endometriosis, hepatic cyst, hysterectomy, neuralgia, pollakiuria, rectocele repair, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.


Rebif Side Effects Report #5748233-6
Consumer or non-health professional from UNITED STATES reported REBIF problem on May 07, 2008. Female patient, 44 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: appendix disorder, carbohydrate antigen 19-9 increased, endometriosis, hepatic cyst, neuralgia, pollakiuria, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.

Sandimmune Side Effects Report #5524830-8
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on Nov 15, 2007. Male patient, 73 years of age, was diagnosed with biliary cirrhosis primary and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, carbohydrate antigen 19-9 increased, carcinoembryonic antigen increased, gamma-glutamyltransferase increased, hepatectomy, hepatic neoplasm malignant, . SANDIMMUNE dosage: 125 MG/DAY. During the same period patient was treated with NEORAL. Patient was hospitalized. Patient recovered.

Xeloda Side Effects Report #5749878-X
Consumer or non-health professional from CHINA reported XELODA problem on May 15, 2008. Male patient, 67 years of age, weighting 112.4 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: bone pain, cachexia, carbohydrate antigen 19-9 increased, carcinoembryonic antigen increased, therapeutic response decreased, tumour marker increased, . XELODA dosage: unknown. Patient recovered.